Andrew Cb Cato

5PUBLICATIONS
57CO-AUTHORS
Molecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Activation of the Aryl Hydrocarbon Receptor-Cytochrome P450 1A1 Axis Mediates the Selective Cytotoxicity of 2‑Phenyl-Imidazo[1,2‑a]Pyridine Derivatives in Triple-Negative Breast Cancer Cells.

|Feb 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan

|Jul 31, 2023
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.

Mengwu Pan, Valeria Solozobova, Nane C Kuznik

|Sep 10, 2021
Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer.

Nane C Kuznik, Valeria Solozobova, Nicole Jung

|Aug 23, 2017
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.

Laura Cato, Antje Neeb, Adam Sharp

Pageof 1

Frequent Collaborators

4 joint publications

Nicole Jung

3 joint publications

Stefan Bräse

2 joint publications

Simone Gräßle

2 joint publications

Victor Gourain